Mon.Jul 18, 2022

article thumbnail

Digital health investment is just cooling off after a scorching year

MedCity News

Digital health startups raised $10.3 billion across 329 deals during the first half of 2022. This putts the sector on track to rake in $21 billion this year, about $8 billion less than the total amount it raised in 2021. The market boom has ended, but the digital health investment space has not come crashing down by any means, according to a recent report.

Marketing 141
article thumbnail

GSK consumer health spin-off Haleon starts trading

pharmaphorum

GSK’s consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with a price of 330 pence and a market valuation of around £31 billion ($37 billion). The new company – which has achieved the largest London listing in a decade – has annual sales of around £10 billion from brands like Sensodyne toothpaste, Voltaren and Panadol painkillers, and Centrum multivitamins, making it the second-largest consumer health company in the world.

Biopharma 122
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How technology is meeting the changing needs of the home health care worker

MedCity News

Serving more patients at home makes efficiency a greater priority for home health care workers and rugged mobile technology is a key differentiator, empowering them to digitize manual workflows.

Patients 134
article thumbnail

Artificial Muscles are Stronger and More Flexible than Real Muscle

Medgadget

Engineers at the University of California Los Angeles created artificial muscles that are stronger and more flexible than the real thing. The new material is an example of a dielectric elastomer, which is an electroactive polymer that can change its shape or size when stimulated using electricity. The researchers tweaked the crosslinking between polymer chains within the material, allowing it to be more flexible while maintaining its strength.

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Geisinger Health Plan addresses burdensome prior auth process with Cohere Health’s platform

MedCity News

Geisinger Health Plan is licensing Cohere Health’s AI-driven utilization management technology and services platform, designed to support value-based care delivery and streamline the prior authorization process.

article thumbnail

FINN Partners Further Expands into Asia with Addition of SPAG

PM360

FINN Partners , an independent marketing and communications agency, is expanding its global footprint even further with the addition of SPAG , a leading, Asia-headquartered, health-sector communications and marketing firm with offices in Bangalore, Delhi, Indonesia, Malaysia, Mumbai, the Philippines, and Singapore. SPAG, which serves global biopharma companies, health trade associations, and health provider systems, is also one of the most awarded agencies in the region having been named Global

More Trending

article thumbnail

How digital health is changing the relationship between patients and health providers

PharmaVoice

The pandemic has forced the pharmaceutical industry to look at digital in a new way - and it’s driving better health outcomes

Patients 105
article thumbnail

Let’s talk about pain

MedCity News

Our nation is severely lacking in its approach to chronic pain. Nobody should ever resign themselves to forever experiencing pain and end their life or the lives of others.

114
114
article thumbnail

How to accelerate clinical study build

pharmaphorum

As you know, clinical trials can be complex. Industry standards are now required for clinical trial submission. This means even more associated costs, resources, time, and effort. The Formedix clinical metadata repository ( MDR ) can help! So what can it do for you? In a nutshell, it can help you: How is this possible? Take studies and standards for example.

article thumbnail

Relatient teams up with RCM company to boost provider adoption of patient engagement tech

MedCity News

Patient engagement SaaS company Relatient recently announced a referral partnership with TriZetto Provider Solutions to offer its suite of patient scheduling and engagement software to their 51,000 provider customers throughout the country. The partnership seeks to increase provider’s access to self-scheduling technology, which is having a hard time taking off due to a lack of physician buy-in.

Patients 113
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Imaging Technique Shows Gene Expression in Real Time

Medgadget

A team at the University of Minnesota developed a new technique that lets them view gene expression in the brains of live mice in real time. The approach relies on two-photon excitation microscopy, specialized imaging processing techniques, and genetically modified mice that express mRNA that naturally includes a fluorescent protein. Using the method, the researchers were able to gain insights into how long-term memories are formed in the brain, and hope that this knowledge could lead to breakth

article thumbnail

Lowering insulin prices isn’t the (only) answer to helping patients with diabetes

MedCity News

It is time to shift the conversation, incentives, and policy solutions to help people improve their health and get off of medications—not just make them cheaper.

Patients 117
article thumbnail

Diamond Sensor for Smaller, Portable MEG Scanners

Medgadget

Researchers at RMIT University in Australia have developed a diamond sensor that can measure magnetic fields up to 10 times more sensitively than current sensors. The breakthrough could lead to a new generation of magnetoencephalography (MEG) scanners that are small and portable, and can function at room temperature. The researchers envisage that the new scanners could even work as a helmet that a patient could place over their head, making it useful in detecting concussions at the point of care

Leads 85
article thumbnail

The Benefits of Workplace Diversity in Medical Sales

MedReps

Just as the landscape of medical sales – the companies, the products, and the customers – is constantly changing, so is the face of the ideal medical sales rep. No longer can companies justify, on an ethical or even financial level, hiring a salesforce based on bias or prejudice. Today’s workplace is more diverse and inclusive than ever, and medical sales leaders can benefit from taking notice.

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

Grünenthal to buy NebidoTM testosterone treatment from Bayer for €500m

European Pharmaceutical Review

Grünenthal has agreed to acquire testosterone treatment Nebido TM and its associated brands from Bayer AG, for up to €500 million. The long-acting injectable treatment for testosterone deficiency has been commercially approved in more than 80 countries. Nebido is also patented until March 2024 in the European Union and until May 2027 in the United States.

article thumbnail

Harper Collins Union Calls One-Day Strike

Copyright Clearance Center

The post Harper Collins Union Calls One-Day Strike appeared first on Copyright Clearance Center.

97
article thumbnail

Dupixent® delivers histological remission for paediatric EoE patients

European Pharmaceutical Review

Treatment with both higher and lower doses of Dupixent ® (dupilumab) resulted in histological disease remission at 16 weeks in children aged one to 11 years with eosinophilic oesophagitis (EoE) – achieving the Phase III trial’s primary endpoint. EoE is a chronic inflammatory disease that damages the oesophagus and prevents it from functioning properly.

article thumbnail

Quoin and Endo sign supply deal for QRX003 in Canada

Pharmaceutical Technology

Quoin Pharmaceuticals and Endo International subsidiary Endo Ventures have signed a licence and distribution agreement and a supply agreement to develop, register, supply, market and distribute the former’s QRX003 exclusively in Canada. A lead product of Quoin, QRX003 is a topical lotion intended to treat Netherton Syndrome. As per the terms of the license and distribution deal, Endo holds the exclusive right, which was also sublicensed to the affiliate of the company, Paladin Labs, to market th

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Drug Regulatory Affairs Certificate Institutes in India

Pharmatutor

Drug Regulatory Affairs Certificate Institutes in India. Historical Overview of Pharmaceutical Industries and Regulatory Affairs:During 1950s, multiple tragedies i.e., sulfanilamide elixir, vaccine tragedy and thalidomide tragedy have resulted in substantial increase of legislations for drug products quality, safety and efficacy. This has also resulted into stricter norms for Marketing Authorization (MA) and Good Manufacturing Practices (GMPs). admin.

Safety 59
article thumbnail

GSK enters agreement with Canada for influenza vaccines

Pharmaceutical Technology

GlaxoSmithKline (GSK) has signed an agreement with the Government of Canada for pandemic and seasonal influenza vaccines to aid in protecting adults and children in the country. Spanning to March 2026, the four-year agreement comprises the delivery of nearly 80 million doses of adjuvanted pandemic influenza vaccine, Arepanrix, and at least four million doses of seasonal influenza vaccine, Flulaval Tetra, each year.

article thumbnail

Byondis cues up US, EU decisions on breast cancer ADC in 2023

pharmaphorum

Byondis has filed its HER2-targeting antibody-drug conjugate (ADC) trastuzumab duocarmazine in the US and Europe, setting up possible approvals next year and a showdown with heavyweight competitors Roche and AstraZeneca/Daiichi Sankyo. The Dutch biotech submitted the ADC to the FDA last week and said this morning the EMA had formally started its review of the drug for HER2-positive, locally advanced or metastatic breast cancer that can’t be treated with surgery.

article thumbnail

EC grants approval for Calliditas’ Kinpeygo to treat IgA nephropathy

Pharmaceutical Technology

The European Commission (EC) has granted conditional marketing authorization (CMA) for Calliditas Therapeutics’ Kinpeygo to treat primary immunoglobulin A (IgA) nephropathy (IgAN) in adults. The treatment is indicated for IgAN patients at risk of quick disease progression risk with a urine protein-to-creatinine ratio (UPCR) ?1.5g/gram. . An orphan medicinal product, Kinpeygo is the first and only therapy to receive approval for IgAN.

Safety 64
article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.

article thumbnail

EMA validates application for Byondis’ trastuzumab duocarmazine

PharmaTimes

The submission follows positive results of phase 3 trial focusing on breast cancer therapy

90
article thumbnail

Addressing the treatment gap in the bronchiectasis market

Pharmaceutical Technology

Bronchiectasis is defined by the permanent and abnormal damage to the bronchi, causing dilation and scarring, and usually occurs in the context of chronic airway infection and inflammation, often with thick and difficult-to-clear mucus. Bronchiectasis occurs across age groups but is most prevalent in adults and more common in females. Symptoms vary from excessive coughing, chest discomfort, and even weight loss, exacerbating other symptoms such as breathlessness.

article thumbnail

EC authorisation granted to kidney disease treatment Kinpeygo

PharmaTimes

The treatment was developed by Calliditas and will be marketed by Stada

article thumbnail

4 Posts About MedTech Sales for Your Summer Holidays

Cesare Ferrari

It’s time for summer holidays, a chance to take some much-needed time on the beach or on the mountain with family and friends. This is the last post before my usual annual summer break, and I wanted to share four posts on MedTech sales that I consider relevant for every MedTech professionals. I will return to your inbox in August. Until then, enjoy this content. 4 Essential MedTech Sales Posts.

Sales 52
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Healthcare Success Launches New Website: Here's What You Can Learn?

Healthcare Success

While we are very excited to announce our agency just launched our new website featuring a brand-new design, functionality, backend tech, and fresh content, we expect you’ll be more interested in the following three takeaways: Why we decided to rebuild our site completely, Why you may need to similarly “start anew” with your website, and. How you can learn and benefit from our experiences.

article thumbnail

Digital health firm Oto raises $3.3m for tinnitus support tool

pharmaphorum

UK startup Oto has raised £2.8 million ($3.3 million) in seed financing for a mobile app that aims to help people with tinnitus manage the ringing, buzzing or other noises in their ears that can wreak havoc with their quality of life. The app doesn’t promise to treat tinnitus – in fact there are no approved therapies for the condition, which affects one in seven people worldwide.

article thumbnail

Content Marketing for Your Medical Practice: Benefits and Tips

LEVO Health

Many medical practices struggle to make the most of their marketing budget. After all, healthcare marketing is an area that some organizations overlook, but it can be successful when done right. Implementing a strategy for content marketing in your medical practice can help your business grow and take your practice to the next level. . If your practice wants to connect with existing and potential patients, you have to create meaningful connections through your marketing efforts.

Medical 52
article thumbnail

Data analytics hiring levels in the pharmaceutical industry rose in June 2022

Pharmaceutical Technology

The proportion of pharmaceutical companies hiring for data analytics related positions rose in June 2022 compared with the equivalent month last year, with 70.1% of the companies included in our analysis recruiting for at least one such position. This latest figure was higher than the 65% of companies who were hiring for data analytics related jobs a year ago and an increase compared to the figure of 67.8% in May 2022.

article thumbnail

Clinical Supply Strategies for CROs

When a CRO is bidding on a project where clinical supplies will be one of the aspects to manage on behalf of the client via a partner, leveraging the expertise of a chosen clinical supply partner can be a valuable resource in demonstrating the CRO’s understanding of and ability to deliver upon critical drug-supply related aspects of the project, and ability to hit key milestones such as FPI for their client.